This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pcDNA-REL 424-490
catalog :
27267
citations: 1
Reference
Starczynowski D, Trautmann H, Pott C, Harder L, Arnold N, Africa J, et al. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity. Oncogene. 2007;26:2685-94 pubmed
product information
Catalog Number :
27267
Product Name :
pcDNA-REL 424-490
article :
doi10.1038/sj.onc.1210089
id3910
pubmed_id17072339
bacterial resistance :
Ampicillin
cloning :
backbonepcDNA3.1(-)
backbone_mutation
backbone_originInvitrogen
backbone_size5400
promoter
sequencing_primer_3
sequencing_primer_5
vector_types
Mammalian Expression
growth notes :
Please note that Addgene's sequencing results confirmed N424 is present in the REL sequence. Despite the plasmid name, amino acids 425-490 of REL have been deleted. This plasmid is exactly as created by the depositing laboratory and as described in the associated publication listed below and in Chin et al., Oncogene. 2009 May 21;28(20):2100-11.
origin :
37
pi :
alt_names
RELdeltaTAD1
cloning
clone_methodRestriction Enzyme
cloning_site_3HindIII
cloning_site_5XbaI
promoter
sequencing_primer_3BGH-Rev
sequencing_primer_5T7
site_3_destroyed
site_5_destroyed
entrez_gene
aliasesC-Rel, HIVEN86A, IMD92
geneREL
id5966
genbank_ids
mutationDeletion of transactivation domain I (aa 425-490)
nameREL
shRNA_sequence
size1563
species
9606
Homo sapiens
tags
resistance markers :
871
tags :
High Copy
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
info@addgene.org
https://www.addgene.org
617.225.9000
headquarters: USA